Investigation of peripheral complement factors across stages of psychosis
暂无分享,去创建一个
Andrew Zalesky | Bernhard T. Baune | Christos Pantelis | Chad Bousman | Barnaby Nelson | Patrick McGorry | Vanessa Cropley | Gursharan Chana | A. Zalesky | C. Pantelis | B. Baune | I. Everall | P. McGorry | B. Nelson | C. Weickert | G. Chana | C. Bousman | L. Laskaris | M. D. Di Biase | V. Cropley | Liliana Laskaris | Cynthia Shannon Weickert | Ian Everall | Maria A. Di Biase | Liliana Laskaris
[1] John D Lambris,et al. The role of complement in inflammatory diseases from behind the scenes into the spotlight. , 2007, The American journal of pathology.
[2] Yanling Hu,et al. Genome-Wide Association Study for Serum Complement C3 and C4 Levels in Healthy Chinese Subjects , 2012, PLoS genetics.
[3] R. Lenroot,et al. Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume , 2015, Molecular Psychiatry.
[4] Tyrone D. Cannon,et al. Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk , 2015, Biological Psychiatry.
[5] N. Barnes,et al. Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis , 2014, Schizophrenia Research.
[6] C. Spencer,et al. Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.
[7] B. Stevens,et al. Microglia function during brain development: New insights from animal models , 2015, Brain Research.
[8] A. Boyajyan,et al. Alternative Complement Pathway in Schizophrenia , 2010, Neurochemical Research.
[9] A. García-Hernández,et al. Acute phase proteins as biological markers of negative psychopathology in paranoid schizophrenia. , 2007, Actas espanolas de psiquiatria.
[10] N. Vasic,et al. Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand? , 2012, European Archives of Psychiatry and Clinical Neuroscience.
[11] J. Overall,et al. The Brief Psychiatric Rating Scale , 1962 .
[12] P. Mortensen,et al. The Epidemiologic Evidence Linking Autoimmune Diseases and Psychosis , 2014, Biological Psychiatry.
[13] Tyrone D. Cannon,et al. Maternal complement C1q and increased odds for psychosis in adult offspring , 2014, Schizophrenia Research.
[14] F. Dickerson,et al. Inflammatory Markers in Recent Onset Psychosis and Chronic Schizophrenia. , 2015, Schizophrenia bulletin.
[15] John D. Lambris,et al. The Classical Complement Cascade Mediates CNS Synapse Elimination , 2007, Cell.
[16] S. Kay,et al. The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.
[17] G. He,et al. Label-free quantitative proteomic analysis reveals dysfunction of complement pathway in peripheral blood of schizophrenia patients: evidence for the immune hypothesis of schizophrenia. , 2012, Molecular bioSystems.
[18] Robert B Sim,et al. Increased complement classical and mannan-binding lectin pathway activities in schizophrenia , 2006, Neuroscience Letters.
[19] M. First,et al. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. , 1992, Archives of general psychiatry.
[20] K. Akinlade,et al. Complement factors in newly diagnosed Nigerian schizoprenic patients and those on antipsychotic therapy. , 2012, Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria.
[21] B. Kirkpatrick,et al. Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects , 2011, Biological Psychiatry.
[22] S. Leucht,et al. Equipercentile linking of the BPRS and the PANSS , 2013, European Neuropsychopharmacology.
[23] R. Murray,et al. Complement system biomarkers in first episode psychosis , 2017, Schizophrenia Research.
[24] W. Tsai,et al. Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8 , 2010, Schizophrenia Research.
[25] Nancy C. Andreasen,et al. Progressive Brain Change in Schizophrenia: A Prospective Longitudinal Study of First-Episode Schizophrenia , 2011, Biological Psychiatry.
[26] F. Turkheimer,et al. PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia , 2017, Translational Psychiatry.
[27] H. Stolp,et al. Review: Role of developmental inflammation and blood–brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases , 2009, Neuropathology and applied neurobiology.
[28] G. Tsakanova,et al. Hyperactivation of the alternative complement cascade in schizophrenia , 2008, Doklady Biochemistry and Biophysics.
[29] Robert B Sim,et al. Complement C4B protein in schizophrenia , 2008, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[30] R. Aroutiounian,et al. Functional characterization of the complement receptor type 1 and its circulating ligands in patients with schizophrenia , 2011, BMC clinical pathology.
[31] D. Dima,et al. An integrated brain-behavior model for working memory , 2017, Molecular Psychiatry.
[32] H. Meltzer,et al. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs , 1997, Psychiatry Research.
[33] Alan S. Brown,et al. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. , 2010, The American journal of psychiatry.
[34] E. Severance,et al. Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia , 2012, Neurobiology of Disease.
[35] Tyrone D. Cannon. How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of Psychosis , 2015, Trends in Cognitive Sciences.
[36] Károly Mirnics,et al. ynaptic changes in the brain of subjects with schizophrenia , 2011 .
[37] R. Veerhuis,et al. Complement in the brain. , 2011, Molecular immunology.
[38] Giulio Genovese,et al. Schizophrenia risk from complex variation of complement component 4 , 2016, Nature.
[39] F. Kapczinski,et al. Increased serum levels of C3 and C4 in patients with schizophrenia compared to eutymic patients with bipolar disorder and healthy. , 2012, Revista brasileira de psiquiatria.
[40] Robert B Sim,et al. Classical pathway complement activity in schizophrenia , 2005, Neuroscience Letters.
[41] E. Bullmore,et al. The University of Birmingham ( Live System ) Are There Progressive Brain Changes in Schizophrenia ? A Meta-Analysis of Structural Magnetic Resonance Imaging Studies , 2016 .
[42] D. Volk,et al. Molecular mechanisms and timing of cortical immune activation in schizophrenia. , 2015, The American journal of psychiatry.
[43] D. Sheehan,et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.
[44] A. Cohen,et al. The structure of negative symptoms within schizophrenia: implications for assessment. , 2006, Schizophrenia bulletin.
[45] I. Feinberg,et al. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? , 1982, Journal of psychiatric research.
[46] A. Vercammen,et al. Rethinking schizophrenia in the context of normal neurodevelopment , 2013, Front. Cell. Neurosci..
[47] B. Barres,et al. The complement system: an unexpected role in synaptic pruning during development and disease. , 2012, Annual review of neuroscience.
[48] A. Yung,et al. Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States , 2005 .
[49] Y. Fang,et al. Plasma levels of Th17-related cytokines and complement C3 correlated with aggressive behavior in patients with schizophrenia , 2016, Psychiatry Research.
[50] M. Obermeier. The positive and negative syndrome scale for schizophrenia , 2012 .
[51] J. Alexander,et al. Complement and blood-brain barrier integrity. , 2014, Molecular immunology.
[52] A. Bialas,et al. Complement System in Neural Synapse Elimination in Development and Disease. , 2017, Advances in immunology.